Literature DB >> 35679951

Multicenter Randomized Controlled Trial of Surveillance Versus Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia: The SURVENT Trial: Study Rationale, Methodology, Innovation, and Implications.

Sachin Wani1, Rhonda F Souza2, Valerie L Durkalski3, Jose Serrano4, Frank Hamilton4, Nicholas J Shaheen5.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35679951      PMCID： PMC9398991          DOI： 10.1053/j.gastro.2022.05.051

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   33.883


× No keyword cloud information.
  24 in total

1.  ASGE guideline on screening and surveillance of Barrett's esophagus.

Authors:  Bashar Qumseya; Shahnaz Sultan; Paul Bain; Laith Jamil; Brian Jacobson; Sharmila Anandasabapathy; Deepak Agrawal; James L Buxbaum; Douglas S Fishman; Suryakanth R Gurudu; Terry L Jue; Sapna Kripalani; Jeffrey K Lee; Mouen A Khashab; Mariam Naveed; Nirav C Thosani; Julie Yang; John DeWitt; Sachin Wani
Journal:  Gastrointest Endosc       Date:  2019-09       Impact factor: 9.427

Review 2.  Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association.

Authors:  Sachin Wani; Joel H Rubenstein; Michael Vieth; Jacques Bergman
Journal:  Gastroenterology       Date:  2016-10-01       Impact factor: 22.682

3.  Aberrant p53 Immunostaining in Barrett's Esophagus Predicts Neoplastic Progression: Systematic Review and Meta-Analyses.

Authors:  Patrick Snyder; Kerry Dunbar; Daisha J Cipher; Rhonda F Souza; Stuart Jon Spechler; Vani J A Konda
Journal:  Dig Dis Sci       Date:  2019-03-26       Impact factor: 3.199

4.  Diagnosis and Management of Barrett's Esophagus: An Updated ACG Guideline.

Authors:  Nicholas J Shaheen; Gary W Falk; Prasad G Iyer; Rhonda F Souza; Rena H Yadlapati; Bryan G Sauer; Sachin Wani
Journal:  Am J Gastroenterol       Date:  2022-04-01       Impact factor: 10.864

5.  Progression of Barrett's esophagus, crypt dysplasia, and low-grade dysplasia diagnosed by wide-area transepithelial sampling with 3-dimensional computer-assisted analysis: a retrospective analysis.

Authors:  Nicholas J Shaheen; Michael S Smith; Robert D Odze
Journal:  Gastrointest Endosc       Date:  2021-09-16       Impact factor: 9.427

6.  Radiofrequency ablation in Barrett's esophagus with dysplasia.

Authors:  Nicholas J Shaheen; Prateek Sharma; Bergein F Overholt; Herbert C Wolfsen; Richard E Sampliner; Kenneth K Wang; Joseph A Galanko; Mary P Bronner; John R Goldblum; Ana E Bennett; Blair A Jobe; Glenn M Eisen; M Brian Fennerty; John G Hunter; David E Fleischer; Virender K Sharma; Robert H Hawes; Brenda J Hoffman; Richard I Rothstein; Stuart R Gordon; Hiroshi Mashimo; Kenneth J Chang; V Raman Muthusamy; Steven A Edmundowicz; Stuart J Spechler; Ali A Siddiqui; Rhonda F Souza; Anthony Infantolino; Gary W Falk; Michael B Kimmey; Ryan D Madanick; Amitabh Chak; Charles J Lightdale
Journal:  N Engl J Med       Date:  2009-05-28       Impact factor: 91.245

7.  Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension.

Authors:  Melanie Calvert; Derek Kyte; Rebecca Mercieca-Bebber; Anita Slade; An-Wen Chan; Madeleine T King; Amanda Hunn; Andrew Bottomley; Antoine Regnault; An-Wen Chan; Carolyn Ells; Daniel O'Connor; Dennis Revicki; Donald Patrick; Doug Altman; Ethan Basch; Galina Velikova; Gary Price; Heather Draper; Jane Blazeby; Jane Scott; Joanna Coast; Josephine Norquist; Julia Brown; Kirstie Haywood; Laura Lee Johnson; Lisa Campbell; Lori Frank; Maria von Hildebrand; Michael Brundage; Michael Palmer; Paul Kluetz; Richard Stephens; Robert M Golub; Sandra Mitchell; Trish Groves
Journal:  JAMA       Date:  2018-02-06       Impact factor: 56.272

8.  Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial.

Authors:  K Nadine Phoa; Frederike G I van Vilsteren; Bas L A M Weusten; Raf Bisschops; Erik J Schoon; Krish Ragunath; Grant Fullarton; Massimiliano Di Pietro; Narayanasamy Ravi; Mike Visser; G Johan Offerhaus; Cees A Seldenrijk; Sybren L Meijer; Fiebo J W ten Kate; Jan G P Tijssen; Jacques J G H M Bergman
Journal:  JAMA       Date:  2014-03-26       Impact factor: 56.272

9.  Early-Onset Esophageal Adenocarcinoma Presents With Advanced-Stage Disease But Has Improved Survival Compared With Older Individuals.

Authors:  Jennifer M Kolb; Samuel Han; Frank I Scott; Caitlin C Murphy; Patrick Hosokawa; Sachin Wani
Journal:  Gastroenterology       Date:  2020-08-08       Impact factor: 33.883

10.  Endoscopic radiofrequency ablation or surveillance in patients with Barrett's oesophagus with confirmed low-grade dysplasia: a multicentre randomised trial.

Authors:  Frederic Prat; Stanislas Chaussade; Maximilien Barret; Mathieu Pioche; Benoit Terris; Thierry Ponchon; Franck Cholet; Frank Zerbib; Edouard Chabrun; Marc Le Rhun; Emmanuel Coron; Marc Giovannini; Fabrice Caillol; René Laugier; Jeremie Jacques; Romain Legros; Christian Boustiere; Gabriel Rahmi; Elodie Metivier-Cesbron; Geoffroy Vanbiervliet; Paul Bauret; Jean Escourrou; Julien Branche; Lea Jilet; Hendy Abdoul; Nadira Kaddour; Sarah Leblanc; Michael Bensoussan
Journal:  Gut       Date:  2021-03-08       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.